Interphysician agreement on subclassification of myocardial infarction

Heart

Volumn 104, Issue 15, 2018, Pages 1284-1291

  Gard, Anton ^a,d   Lindahl, Bertil ^a   Batra, Gorav ^a   Hadziosmanovic, Nermin ^a   Hjort, Marcus ^a   Szummer, Karolina Elisabeth ^b,c   Baron, Tomasz ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA CLINICAL RESEARCH CENTER   (Sweden)

Author keywords

acute coronary syndromes; acute myocardial infarction

Indexed keywords

C REACTIVE PROTEIN; TROPONIN;

AGED; ARTICLE; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; DISEASE CLASSIFICATION; DYSPNEA; FEMALE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; KAPPA STATISTICS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SWEDEN; SYSTOLIC BLOOD PRESSURE; CLASSIFICATION; CLINICAL DECISION MAKING; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; OBSERVER VARIATION; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CLINICAL DECISION-MAKING; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBSERVER VARIATION; SWEDEN;

EID: 85049136131     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2017-312409     Document Type: Article

References (22)

1. Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACC F/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Eur Heart J 2007;28:2525-38.
2. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012;60:1581-98.
3. Saaby L, Poulsen TS, Hosbond S, et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med 2013;126:789-97.
4. Sandoval Y, Thordsen SE, Smith SW, et al. Cardiac troponin changes to distinguish type 1 and type 2 myocardial infarction and 180-day mortality risk. Eur Heart J Acute Cardiovasc Care 2014;3:317-25.
5. Shah AS, McAllister DA, Mills R, et al. Sensitive troponin assay and the classification of myocardial infarction. Am J Med 2015;128:493-501.
6. Jernberg T, Attebring MF, Hambraeus K, et al. The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart 2010;96:1617-21.
7. Harnek J, Nilsson J, Friberg O, et al. The 2011 outcome from the Swedish Health Care Registry on Heart Disease (SWEDEHEART). Scand Cardiovasc J 2013;47(Suppl 62):1-10.
8. Javed U, Aftab W, Ambrose JA, et al. Frequency of elevated troponin I and diagnosis of acute myocardial infarction. Am J Cardiol 2009;104:9-13.
9. Ambrose JA, Loures-Vale A, Javed U, et al. Angiographic correlates in type 1 and 2 MI by the universal definition. JACC Cardiovasc Imaging 2012;5:463-4.
10. Lippi G, Sanchis-Gomar F, Cervellin G. Chest pain, dyspnea and other symptoms in patients with type 1 and 2 myocardial infarction. A literature review. Int J Cardiol 2016;215:20-2.
11. Saaby L, Poulsen TS, Diederichsen AC, et al. Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort. Am J Med 2014;127:295-302.
12. Baron T, Hambraeus K, Sundström J, et al. Type 2 myocardial infarction in clinical practice. Heart 2015;101:101-6.
13. Cediel G, Gonzalez-Del-Hoyo M, Carrasquer A, et al. Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury. Heart 2017;103.
14. Sarkisian L, Saaby L, Poulsen TS, et al. Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevated troponins. Am J Med 2016;129:446.e5-446.e21.
15. Landes U, Bental T, Orvin K, et al. Type 2 myocardial infarction: a descriptive analysis and comparison with type 1 myocardial infarction. J Cardiol 2016;67:51-6.
16. Smilowitz NR, Weiss MC, Mauricio R, et al. Provoking conditions, management and outcomes of type 2 myocardial infarction and myocardial necrosis. Int J Cardiol 2016;218:196-201.
17. Januzzi JL, Filippatos G, Nieminen M, et al. Troponin elevation in patients with heart failure: on behalf of the third universal definition of myocardial infarction global task force: heart failure section. Eur Heart J 2012;33:2265-71.
18. Newby LK, Jesse RL, Babb JD, et al. ACC F 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2012;60:2427-63.
19. McMurray JJV, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur J Heart Fail 2012;14:803-69.
20. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
21. Wang J, Tan GJ, Han LN, et al. Novel biomarkers for cardiovascular risk prediction. J Geriatr Cardiol 2017;14:135-50.
22. Agewall S, Giannitsis E, Jernberg T, et al. Troponin elevation in coronary vs. noncoronary disease. Eur Heart J 2011;32:404-11.